A double-blind randomized placebo-controlled trial with short-term beta-glucuronidase therapy in children with chronic rhinoconjunctivitis and/or asthma due to dust mite allergy. J Investig Allergol Clin Immunol. 2006; 16(6):345-50. PMID: 17153881 [PubMed – indexed for MEDLINE]
Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome. Lancet. 1992 May 9;339(8802):1150-3.
McEwen LM. Ganderton MA. Wilson CW. Black JH. Hyaluronidase in the treatment of allergy. British Medical Journal. ii: 507-8, 1967.
McEwen LM. Starr MS. Enzyme potentiated hyposensitization I: The effect of pre-treatment with beta-glucuronidase, hyaluronidase and antigen on anaphylactic sensitivity of guinea pigs, rats and mice. International Archives of Allergy. 42:152-8, 1972.
McEwen LM. Enzyme potentiated hyposensitization II: Effect of glucose, glucosamine, N-acetylamino-sugars and gelatin on the ability of beta- glucuronidase to block the anamnestic response to antigen in mice. Annals of Allergy. 31:79-83,1973.
McEwen LM. Effects of sugars and diols on enzyme potentiated desensitization.Journal of Physiology. 230(1): 65-6, 1973 Apr.
McEwen LM. Nicholson M. Kitchen I. White S. Enzyme potentiated hyposensitization III: Control by sugars and diols of the immunological effect of beta-glucuronidase in mice and patients with hay fever. Annals of Allergy. 31(11), 543-50, 1973.
McEwen LM. Nicholson M. Kitchen I. O’Gorman J. White S. Enzyme potentiated hyposensitization IV: Effect of protamine on the immunological behavior of beta-glucuronidase in mice and patients with hay fever. Annals of Allergy. 34:290-5,1975.
McEwen LM. Enzyme potentiated hyposensitization V: Five case reports of patients with acute food allergy. Annals of Allergy. 35:98-103,1975.
McEwen LM. A double-blind controlled trial of enzyme potentiated hyposensitization for the treatment of ulcerative colitis. Clinical Ecology. 5(2): 47-51, 1987.
McEwen LM. Hyposensitization. In: Brostoff J and Challacombe SJ., Eds. Food allergy and intolerance. London; Bailliere Tindall, 985-94, 1987.
Fell P. Brostoff JA. Single dose desensitization for summer hay fever. European Journal of Clinical Pharmacology. 38: 77-9,1990.
Eaton KK. Preliminary studies with enzyme potentiated desensitization in canine atopic dermatitis. Environmental Medicine. 8:140-1,1991.
Longo G. Poli F. Bertoli G. Efficacia clinica di UN novo trattemento iposensibilizzante, EPD (enzyme potentiated desensitization) nella terapia Della pollinosi. Reforma Medica. 107:171-6,1992.
Eggar J. Stolla A. McEwen LM. Controlled trial of hyposensitization in children with food-induced hyperkinetic syndrome. Lancet. 339:1150-3, 1992 May 9.
Shrader Jr. WA. McEwen LM. Enzyme potentiated desensitization: A sixteen month trial of therapy with 134 patients. Environmental Medicine. 9 (3&4): 128-38, 1993.
Angelini G. Curatoli G. D’Argento V. Vena GA. Pollinosi: una nuova metodica di immunoterapia.Medit. J. Surg. Med., 253-6, 1993
Eggar J. Stolla A. McEwen L.M. Hyposensibilisierung bei nahrungsmittelinduzierter migrane. Actuelle Neuropadiatrie. 1992. A. Lishka, G. Bernett (Eds.) 1992. 287-291. Ciba-Geigy Verlag, Wehr 1993.
Eggar J. Stolla A. McEwen LM. Controlled trial of hyposensitization in children with food induced migraine. Cephalgia.13: Suppl. 216, 1993.
Di Stanislao C. Mazzocchetti E. Bologna G Chimenti S. EPD secondo McEwen: Studio cliniico, istologia e immunoistochimico. Bollentino de dermatologia allergologia e professionale, 2, 1994
Astarita C. et al. Effects of enzyme potentiated desensitization in the treatment of pollinosis: A double-blind placebo-controlled trial. Journal of Investigational Allergology and Clinical Immunology 6(4): 248-255, 1996 July-Aug.
Cantani A. Vanda Ragno V. Monteleone A. Lucenti P. Businco L. Enzyme-potentiated desensitization in children with asthma and mite allergy: A double-blind study. Journal of Investigational Allergology and Clinical Immunology. 6(4): 270-76, 1996 Jul.-Aug.
Galland L. McEwen L.M. A role for food intolerance in childhood migraine. World Ped. & Child Care. 6: 2-8, 1996.
Pulec JL. Enzyme-potentiated desensitization: a major breakthrough [editorial]. Ear, Nose, & Throat Journal. 75(10): 640, 1996 Oct.
Caramia G. Franceschini F. Cimarelli ZA. Ciucchi MS. Gagliardini R. Ruffini E. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children. Allergie et Immunologie. 28(9): 308-10, 1996 Nov.
Ippoliti F. Rivi R. Businco L. Effect of preseasonal enzyme potentiated desensitization (EPD) on plasma IL-6 and IL-10 in grass pollen-sensitive asthmatic children. Allergie et Immunologie; 29(5): 120, 123-25, 1997.
Di Stanislao C. Mazzocchetti E. Bologna G Chimenti S. A double-blind, placebo-controlled study of preventative immunotherapy with EPD in the treatment of seasonal allergic disease. Allergie et immunologie. 29(2): 39-42, 1997.
Ward WA. Enzyme potentiated desensitization (EPD): a potential revolution in allergy care. Current Opinion in Otolaryngology & Head and Neck Surgery. 8:273-6, 2000.
Shrader, Jr. WA. The use of bacterial antigen EPD immunotherapy for the treatment of rheumatoid arthritis and reactive arthritis: the role of molecular mimicry (unpublished), 1996, revised 1998, 2000.
Shrader, W.A., Treating Allergies with EPD Immunotherapy, in Optimal Digestion, Faas, N., 370-78, Harper-Collins, 1999.
Shrader, Jr., W.A. Short and long-term treatment of asthma with intravenous nutrients. Nutr J. May 14 2004; 3(1): 6.